Product development

SALMOSS HAP

Is our first product in development. It is a new and unique non-human, non-mammal derived xenograft. It has no conflict with kosher or halal communities and is free of bovine prion disease. It favors cyclic economy while creating a positive environmental impact.

hap10001

SALMOSS BIOTECH STEPS

July 2023
Introduced
SALMOSS BIOTECH is created
August 2023
Introduced
Provisional Patent Filing
September 2023
Expanded
Partnership with Pontificia Universidad Católica de Chile
November 2023
Expanded
Was nominated and selected to participate in IDEA2 program from MIT

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

SALMOSS Biotech

We harness the power of science to transform ideas into solutions, creating a positive impact on global health and contributing to a sustainable future.